Senolytic therapy to modulate the progression of Alzheimer’s Disease (SToMP-AD) – Outcomes from the first clinical trial of senolytic therapy for Alzheimer's disease
Miranda E. Orr(Wake Forest University), Nicolas Musi(Audie L. Murphy Memorial VA Hospital)
Cited by 37
Related Papers
Elevated Muscle TLR4 Expression and Metabolic Endotoxemia in Human Aging
|The Journals of Gerontology Series A|2014|150
A low dose lipid infusion is sufficient to induce insulin resistance and a pro-inflammatory response in human subjects
|PLoS ONE|2018|29
Antenatal corticosteroids alter insulin signaling pathways in fetal baboon skeletal muscle
|Journal of Endocrinology|2014|16